INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

agilon health, inc.

AGLCIK 0001831097

EDGAR filingsOpen in network
Price$113.77
1 year+528.6%
Disclosed transactions1
Buys / sells0 / 0
Max Insider Score21
Connections with evidence3

AGL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
SA
Schwaneke Jeffrey A.Chief Financial Officer
AGLagilon health, inc.
Grant or award
A—
600.0K sh
Jan 10, 2026Jan 13, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8090 · Services-Misc Health & Allied Services, NEC · Nov 4, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Schwaneke Jeffrey A.Chief Financial Officer · Jan 13, 2026
traded Jan 10, 2026
+3d
SEC FORM 4

Evidence

Lobbying

$250K reported · de-duplicated
2026 Q2 $100K in-house2026 Q1 $150K in-house
  • In-house report$150K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
  • In-house report$100K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
  • TIBER CREEK GROUP$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
  • TIBER CREEK GROUP$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.